Find a Study

STUDY SEARCH RESULTS

Notify Me When Search is Updated

351 studies found for your search request: cancer

18F-FLT-PET in Breast Cancer (MK-0000-139)
Condition: Breast Cancer
Minimum Age: 35 years, Maximum Age: 75 years
Gender: Female
Study ID: NCT01015131
Status: Completed

A clinical study of MK-2870 alone or with chemotherapy to treat gastrointestinal cancers (MK-9999-02...
Condition: Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT06428409
Status: Recruiting
Has Enrolling Locations in US or Canada

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients with Bladder Cancer (MK-2870-027)
Condition: Non-Muscle Invasive Bladder Cancer
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT06637423
Status: Not yet recruiting

A Clinical Study of V940 plus Pembrolizumab in People with High-Risk Melanoma (V940-001)
Condition: Melanoma
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT05933577
Status: Active, not recruiting

A clinical study of V940 treatment and pembrolizumab in people with bladder cancer (V940-005/INTerpa...
Condition: Bladder Cancer
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT06305767
Status: Recruiting
Has Enrolling Locations in US or Canada

Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences Privacy Terms of Use Consumer Health Data Privacy Policy Your Privacy Choices Accessibility U.S. Corporate Site